within Pharmacolibrary.Drugs.ATC.G;

model G04BD09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.096,
    Cl             = 0.0010166666666666666,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.395,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.006,
    Tlag           = 19.8
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G04BD09</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Trospium is a quaternary ammonium antimuscarinic agent used in the treatment of overactive bladder with symptoms of urge incontinence, urgency, and urinary frequency. It acts as a muscarinic antagonist that inhibits involuntary contractions of the bladder. Trospium is approved and in current use for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers (mixed sex, n=24), following a single oral dose under fasting conditions.</p><h4>References</h4><ol><li><p>Abebe, BT, et al., &amp; Siegmund, W (2019). Effects of the P-Glycoprotein Inhibitor Clarithromycin on the Pharmacokinetics of Intravenous and Oral Trospium Chloride: A 4-Way Crossover Drug-Drug Interaction Study in Healthy Subjects. <i>Journal of clinical pharmacology</i> 59(10) 1319–1330. DOI:<a href=\"https://doi.org/10.1002/jcph.1421\">10.1002/jcph.1421</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30973998/\">https://pubmed.ncbi.nlm.nih.gov/30973998</a></p></li><li><p>Doroshyenko, O, et al., &amp; Fuhr, U (2005). Clinical pharmacokinetics of trospium chloride. <i>Clinical pharmacokinetics</i> 44(7) 701–720. DOI:<a href=\"https://doi.org/10.2165/00003088-200544070-00003\">10.2165/00003088-200544070-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15966754/\">https://pubmed.ncbi.nlm.nih.gov/15966754</a></p></li><li><p>Chapple, C (2010). New once-daily formulation for trospium in overactive bladder. <i>International journal of clinical practice</i> 64(11) 1535–1540. DOI:<a href=\"https://doi.org/10.1111/j.1742-1241.2010.02493.x\">10.1111/j.1742-1241.2010.02493.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20846201/\">https://pubmed.ncbi.nlm.nih.gov/20846201</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G04BD09;
